May 7, 2026 04:01PM
Apr 28, 2026 09:28AM
Feb 19, 2026 04:01PM
Feb 18, 2026 05:31PM
Feb 12, 2026 05:00PM
Feb 12, 2026 05:00PM
Jan 12, 2026 08:31AM PTC Therapeutics reports Q4 Sephience revenue of $92.5 million
Jan 12, 2026 08:30AM
Nov 16, 2025 03:00PM
Nov 5, 2025 04:45AM
Nov 4, 2025 04:01PM
Nov 3, 2025 10:00AM
Sep 8, 2025 09:44AM
Aug 19, 2025 12:11PM Goldman Sachs Reiterates Sell Rating on PTC Therapeutics (PTCT)
Aug 19, 2025 11:49AM
Aug 19, 2025 11:01AM
Aug 19, 2025 10:50AM
Aug 19, 2025 08:01AM
Aug 19, 2025 08:00AM
Aug 7, 2025 04:01PM
Jul 29, 2025 10:08AM PTC Therapeutics (PTCT) PT Raised to $80 at UBS
Jul 29, 2025 08:30AM
Jul 28, 2025 04:19PM
Jul 28, 2025 04:19PM
Jul 14, 2025 09:56AM
Jun 23, 2025 07:00AM
Jun 2, 2025 10:33AM
Jun 2, 2025 10:23AM RBC Capital Reiterates Outperform Rating on PTC Therapeutics (PTCT)
May 7, 2025 06:00AM
May 6, 2025 04:01PM
May 5, 2025 02:48PM
Apr 25, 2025 09:00AM
Apr 25, 2025 09:00AM
Apr 12, 2025 04:00AM
Mar 11, 2025 05:20AM BofA Securities Upgrades PTC Therapeutics (PTCT) to Neutral
Feb 27, 2025 04:01PM
Feb 19, 2025 10:31AM
Feb 19, 2025 07:01AM
Feb 19, 2025 07:00AM
Jan 13, 2025 12:50PM
Jan 13, 2025 09:08AM
Jan 13, 2025 09:00AM PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference
Jan 6, 2025 10:35AM
Dec 19, 2024 08:02AM
Dec 19, 2024 08:00AM
Dec 4, 2024 05:50AM
Dec 2, 2024 04:14PM
Nov 27, 2024 07:00AM
Nov 27, 2024 07:00AM PTC Therapeutics Enters into Agreement to Sell Priority Review Voucher for $150 Million
Nov 13, 2024 06:02PM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All